Matthew L. Posard Insider Trading $XNOM.OB Cardiff Oncology, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew L. Posard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew L. Posard. Matthew L. Posard is Sr VP & General Manager in ILLUMINA INC ($ILMN) and Sr VP & GM, Consumer Genomics in ILLUMINA INC ($ILMN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Commercial Officer in Trovagene, Inc. ($XNOM.OB) and Director in Talis Biomedical Corp ($TLIS) and Director in DermTech, Inc. ($DMTK).
Matthew L. Posard in Cardiff Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Matthew L. Posard: Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: Jan 06 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Matthew L. Posard in Cardiff Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XNOM.OB, DMTK, GYHT, ILMN, TLIS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2016 | XNOM.OB | Trovagene, Inc. | Posard Matthew L. | Chief Commercial Of ... | Option Exercise | A | 5.18 | 150,000 | 777,000 | 650,000 |
Page: 1